A Framework for Pharmacist Development in ... - …
About CoDEG The Competency Development and Evaluation Group (CoDEG) is a collaborative network of developers and researchers, practitioners, specialist …
Download A Framework for Pharmacist Development in ... - …
Information
Domain:
Source:
Link to this page:
Documents from same domain
Guidance for the Development of Consultant …
www.codeg.orgExecutive Summary In 2003, the consultant pharmacist role was identified in ‘A Vision for Pharmacy in the New NHS’.This new role offers an opportunity to make a greater difference to patient care and
Adult Critical Care: Specialist Pharmacy Practice - CoDEG
www.codeg.orgNew Ways of Working – Adult Critical Care Specialist Pharmacy Practice Page 3 of 27 The Project will deliver this by: - 2.1 Helping define professional roles and responsibilities within critical care pharmacy
Related documents
Career Information : No points are allocated for ten …
www.dut.ac.zaCareer Information Bachelor of Health Sciences in Clinical Technology . Location . ML Sultan Campus (B Block 2 nd Floor) Purpose of the programme The purpose of this qualification is to develop a learner to possess
COMMITTEE FOR MEDICINAL PRODUCTS FOR …
www.ema.europa.euIt clarifies the requirements for clinical documentation for abridged applications for orally inhaled formulations and variations/extensions to a marketing authorisation, and including both single active substance products
Guideline on clinical development of fixed …
www.ema.europa.euThis is the nd2 revision of the guideline on clinical development of fixed combination medicinal products containing two or more active substances within a single pharmaceutical form.
GENERAL CLINICAL DOCUMENTATION AND …
www.himaa.org.auHIMAA Practice Brief 1 – General Documentation & Information Requirements 5 of 42 December 2006 V.1.0 4.0 GLOSSARY The following is a list of terms, associated definitions and concepts used in this
DEVELOPMENT SAFETY UPDATE REPORT - ICH
www.ich.orgThe Development Safety Update Report (DSUR) proposed in this guideline is intended to be a common standard for periodic reporting on drugs under development (including
MEDICINES CONTROL COUNCIL - mccza.com
www.mccza.comRegistration of Medicines Biosimilars . MEDICINES CONTROL COUNCIL. BIOSIMILAR MEDICINES QUALITY, NON-CLINICAL AND CLINICAL REQUIREMENTS
CLINICAL CONSIDERATIONS FOR EVALUATION OF …
www.who.intPage 4 of 8 2.4 Clinical development programme The applicant should provide in the PSF a tabulated summary of the clinical development programme, in one or more tables, in which critical parameters that may have changed
Related search queries
CLINICAL, Requirements for clinical documentation for, Clinical development of fixed, Clinical development of fixed combination medicinal, CLINICAL DOCUMENTATION, Documentation, Requirements, Development Safety Update Report, Development, MEDICINES CONTROL COUNCIL, CLINICAL REQUIREMENTS, CLINICAL CONSIDERATIONS FOR EVALUATION OF, Clinical development